Publication

Article

Supplements and Featured Publications
Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations [CME
Volume 21
Issue 5 Suppl

Participating Faculty: Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations

Faculty

This supplement to The American Journal of Managed Care provides an epidemiological and clinical overview of HCV, discusses current and emerging pharmacotherapeutic strategies for the disease, evaluates the burdens of HCV infection, and examines the new and evolving standards of care from a managed care perspective.

Yekaterina Opsha, PharmD, BCPS

Clinical Assistant Professor

Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey

Piscataway, New Jersey

Clinical Specialist, Cardiovascular Medicine

Saint Barnabas Medical Center

Livingston, New Jersey

Gary M. Owens, MD

President

Gary Owens Associates

Ocean View, Delaware

Monica Shah, PharmD

Antimicrobial Stewardship Clinical Pharmacist

Pharmacy Department

Monmouth Medical Center

Long Branch, New Jersey

Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD

Betty and Guy Beatty Center for Integrated Research

Liver and Obesity Research Center

Chairman

Department of Medicine

Vice President for Research

Inova Health System

Falls Church, Virginia

Editorial Support

Angela K. Kuehl, PharmD, MS

Hitt Medical Writing, LLC

Alpharetta, Georgia

Faculty Disclosures

Yekaterina Opsha, PharmD, BCPS, has no relevant financial relationships with commercial interests to disclose.

Gary M. Owens, MD, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:

Consultant: AbbVie, Janssen, Towers Watson

Monica Shah, PharmD, has no relevant financial relationships with commercial interests to disclose.

Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:

Consultant:

AbbVie, Bristol-Myers Squibb, Enterome, GlaxoSmithKline, Gilead Sciences, Intercept, Salix

Advisory board member:

Janssen, Salix, Vertex

Editorial Support

Angela K. Kuehl, PharmD, MS, has no relevant commercial financial relationships or affiliations to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh, and Ida Delmendo have no relevant financial relationships with commercial interests to disclose.

University of Cincinnati

Planning Staff—Susan P. Tyler, MEd, CMP, CCMEP, Director, University of Cincinnati, has nothing to disclose.

CME Physician Reviewer—Rick Ricer, MD, University of Cincinnati, has nothing to disclose.

Pharmacy Times Office of Continuing Professional Education

Planning staff—David Heckard; Steve Lin, PharmD, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of the University of Cincinnati, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of the University of Cincinnati and Pharmacy Times Office of Continuing Profession Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

The information provided in this CE/CME activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Office of Continuing Professional Education, and the University of Cincinnati, or any of the companies that provided commercial support for this CE/CME activity.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo